Chapter 17: Concepts of Care for Patients With HIV Disease

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Understanding transmission routes—including blood, semen, vaginal secretions, breast milk, and perinatal exposure—is essential for nurses to implement appropriate precautions and provide accurate patient education that reduces stigma associated with the disease. The chapter delineates the clinical stages of HIV infection, from the acute phase characterized by flu-like symptoms and elevated viral load, through the extended period of clinical latency where patients remain asymptomatic despite ongoing viral replication, to the final progression to AIDS. Laboratory assessment and monitoring form a cornerstone of HIV management, incorporating CD4+ T-cell counts, viral load quantification, and resistance testing to guide clinical decision-making. Antiretroviral therapy utilizing combinations of at least three drug classes suppresses viral replication, preserves immune function, and reduces transmission risk, though strict medication adherence remains critical to prevent resistance development. The chapter addresses the spectrum of opportunistic infections and malignancies that emerge as immune function deteriorates, including Pneumocystis jirovecii pneumonia, tuberculosis, candidiasis, cytomegalovirus, toxoplasmosis, Kaposi's sarcoma, and non-Hodgkin lymphoma, along with associated complications such as wasting syndrome and chronic diarrhea. Nursing interventions encompass infection prevention strategies, medication management, symptom relief, and nutritional support. Prevention approaches including pre-exposure prophylaxis for high-risk populations and post-exposure prophylaxis following potential exposure exposure provide additional protective mechanisms. The chapter emphasizes the psychosocial dimensions of HIV care, recognizing that patients experience stigma, depression, anxiety, and social isolation requiring compassionate support, resource coordination, and advocacy for confidentiality. Ethical considerations including partner notification, disclosure practices, and informed consent demand sensitivity and adherence to legal and regulatory frameworks. End-stage care transitions toward palliative and hospice-focused management emphasizing symptom control, comfort, and dignity while supporting family caregivers throughout the disease trajectory.